BRPI0921027A8 - Cepas de vacina de brachyspira hyodysenteriae - Google Patents

Cepas de vacina de brachyspira hyodysenteriae

Info

Publication number
BRPI0921027A8
BRPI0921027A8 BRPI0921027A BRPI0921027A BRPI0921027A8 BR PI0921027 A8 BRPI0921027 A8 BR PI0921027A8 BR PI0921027 A BRPI0921027 A BR PI0921027A BR PI0921027 A BRPI0921027 A BR PI0921027A BR PI0921027 A8 BRPI0921027 A8 BR PI0921027A8
Authority
BR
Brazil
Prior art keywords
vaccine strains
brachyspira hyodysenteriae
present
relates
hyodysenteriae
Prior art date
Application number
BRPI0921027A
Other languages
English (en)
Inventor
J Hampson David
La Tom
I Bellgard Matthew
D Phillips Nyree
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Univ Murdoch
Spirogene Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905922A external-priority patent/AU2008905922A0/en
Application filed by Boehringer Ingelheim Vetmedica Gmbh, Univ Murdoch, Spirogene Pty Ltd filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of BRPI0921027A2 publication Critical patent/BRPI0921027A2/pt
Publication of BRPI0921027A8 publication Critical patent/BRPI0921027A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)

Abstract

CEPAS DE VACINA DE BRACHYSPIRA HYODYSENTERIAE. A presente invenção refere-se, de modo geral, a cepas de vacina de Brachyspira hyodysenteriae. Em particular, a presente invenção refere-se a cepas de vacina vivas isoladas de B. hyodysenteriae carecendo de um ou mais fatores de virulência. A presente invenção refere-se também a métodos de identificação e preparo de cepas de vacina, bem como composições de vacina contra doenças diarreicas e métodos e kits para diagnóstico das mesmas.
BRPI0921027A 2008-11-14 2009-11-13 Cepas de vacina de brachyspira hyodysenteriae BRPI0921027A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008905922A AU2008905922A0 (en) 2008-11-14 Vaccine strains of brachyspira hyodysenteriae
US11550908P 2008-11-17 2008-11-17
PCT/AU2009/001482 WO2010054437A1 (en) 2008-11-14 2009-11-13 Vaccine strains of brachyspira hyodysenteriae

Publications (2)

Publication Number Publication Date
BRPI0921027A2 BRPI0921027A2 (pt) 2015-12-29
BRPI0921027A8 true BRPI0921027A8 (pt) 2017-09-19

Family

ID=42169538

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921027A BRPI0921027A8 (pt) 2008-11-14 2009-11-13 Cepas de vacina de brachyspira hyodysenteriae

Country Status (10)

Country Link
US (1) US9011878B2 (pt)
EP (1) EP2352518A4 (pt)
JP (1) JP2012508564A (pt)
KR (1) KR20110092306A (pt)
CN (1) CN102281893A (pt)
AU (1) AU2009316239B2 (pt)
BR (1) BRPI0921027A8 (pt)
CA (1) CA2743660A1 (pt)
MX (1) MX2011005135A (pt)
WO (1) WO2010054437A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992938B2 (en) * 2007-08-03 2015-03-31 Matthew Bellgard Genes and proteins of Brachyspira hyodysenteriae and uses thereof
DK2935314T3 (da) 2012-12-21 2022-08-15 Boehringer Ingelheim Vetmedica Gmbh Nye rekombinante ydre membranproteiner fra Brachyspira hyodysenteriae og anvendelser deraf
ES2828873T3 (es) * 2013-06-28 2021-05-27 Aquilon Cyl S L Vacuna contra la disentería porcina
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
KR20180094116A (ko) * 2016-01-07 2018-08-22 유니버시테이트 젠트 브라키스피라 하이오디센테리애의 백신 균주
AU2018200954B2 (en) * 2017-03-23 2018-11-22 Australasian Pork Research Institute Ltd Live Vaccine Strains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US582655A (en) * 1897-05-18 Apparatus for manufacturing gas
ES2171393T3 (es) * 1991-12-23 2002-09-16 Dimminaco Ag Vacuna contra la serpulina hyodysenteriae.
WO1998020899A1 (en) 1996-11-12 1998-05-22 Board Of Regents University Of Nebraska Lincoln Attenuated serpulina hyodysenteriae mutant for prevention of swine dysentery
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine

Also Published As

Publication number Publication date
EP2352518A4 (en) 2013-07-10
AU2009316239A1 (en) 2010-05-20
EP2352518A1 (en) 2011-08-10
CN102281893A (zh) 2011-12-14
AU2009316239B2 (en) 2017-10-19
CA2743660A1 (en) 2010-05-20
MX2011005135A (es) 2011-10-24
WO2010054437A1 (en) 2010-05-20
US20110293661A1 (en) 2011-12-01
BRPI0921027A2 (pt) 2015-12-29
US9011878B2 (en) 2015-04-21
JP2012508564A (ja) 2012-04-12
KR20110092306A (ko) 2011-08-17

Similar Documents

Publication Publication Date Title
BR112012004698A2 (pt) métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada.
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
BRPI0921027A8 (pt) Cepas de vacina de brachyspira hyodysenteriae
BR112013000537A2 (pt) composição aquosa contendo bromexina
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
BR112014015851A2 (pt) proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
CO6382140A2 (es) Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada
BR112012029917A2 (pt) composições de nanotransportador com adjuvante desacoplado
BRPI0607374A2 (pt) vacinas de vesìculas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
MY173008A (en) Methods and compositions for improving gut microbiota population
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
BR112015006402A2 (pt) conjunto de pelo menos uma proteína vegetal e pelo menos uma proteína láctea
PE20142115A1 (es) Composiciones de neisseria meningitidis y metodos de las mismas
BR112017011067A2 (pt) cepas e métodos para a partição de energia em ruminantes
BRPI0813307C1 (pt) composição imunogênica, vacina, e, processo para fabricar a vacina
BR112012001764A8 (pt) Método para prover um programa de treinamento incluindo pelo menos um primeiro exercício e um segundo exercício e sistema para prover a um indivíduo um programa de treinamento incluindo pelo menos um primeiro exercício e um segundo exercício
BR112012028291A2 (pt) composições farmacêuticas e métodos para sua produção
BR112015023797A2 (pt) proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
BR112012022874A2 (pt) composições de lacas em pós curáveis por calor, seu processo de produção e uso das mesma
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
BR112015004515A2 (pt) composição imunogênica
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
BR112016007671A2 (pt) adição em estágio tardio de modificador de reologia
BR112013003883A2 (pt) composições que compreendem paulownina e/ou extratos de paulônia e usos das mesmas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SPIROGENE PTY. LTD. (AU)

B25A Requested transfer of rights approved

Owner name: MURDOCH UNIVERSITY (AU)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) , MURDOCH

B25A Requested transfer of rights approved

Owner name: SPIROGENE PTY. LTD. (AU)

B25A Requested transfer of rights approved

Owner name: MURDOCH UNIVERSITY (AU)

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2540 DE 10-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.